Updated/Latest Advanced Assessment Interpreting Findings and Formulating Differential Diagnoses 4th Edition Mary Jo Goolsby Laurie Grubbs Test Bank Complete All Chapters Comprehensive Advanced Health Assessment Resource Practice Questions Answers Rational

Test Bank YFT L




Abrams' Clinical Drug Therapy: Rationales L
YF
T L
T
F
Y L
YF
T L
YF
T




for Nursing Practice YFT L YFT L YFT L




13th EditionL
YF
T




by Geralyn Frandsen & Sandra Pennington
L
YFT YFT L YFT L YFT L YFT L




Complete Chapter Guide 1-61 With Rationales| A+ PASS
L
YFT L
YFT L
YFT L
YFT L
YFT L
YFT L
YFT




1|P a g e
L
YFT L
YFT YFT L Y FT L Y FT L

, Table of Content Y FT L YFT L




YFT L SECTION 1 The Conceptual Framework of Pharmacology YFT L YFT L YFT L Y FT L YFT L YFT L




YFT L Chapter 1 The Foundation of Pharmacology: Quality and Safety
YFT L L
YFT YFT L L
YFT L
YFT YFT L L
YFT L
YFT




YFT Chapter 2 Basic Concepts and Processes
L YFT L YF T L Y FT L YFT L Y FT L




Chapter 3 Medication Administration and the Nursing Process of Drug Therapy
L
YFT L
YFT L
YFT YFT L YFT L YFTL L
YFT L
YFT L
YFT L
YFT




SECTION 2 Drug Therapy Throughout the Lifespan YFT L YFT L YFT L YFT L YFT L YFT L




Chapter 4 Pharmacology and the Care of Infants and Pediatric Patients Medication Administration in
YFT L YFT L L
YFT L
YFT YFT L L
YFT L
YFT L
YFT L
YFT YFT L YFT L L
YFT L
YFT




Pediatrics
YFT L




Chapter 5 Pharmacology and the Care of Adults and Geriatric Patients
YFT L YFT L YF T L YFT L YF T L YFT L L
YF T YFT L Y FT L YF T L




YFT Chapter 6 Pharmacology and the Care of Pregnant or Lactating Woman
L YFT L YFT L L
YFT YFT L YFTL L
YFT L
YFT YFT L YFT L L
YFT




YFT Chapter 7 Pharmacology and Women‘s Health
L YFT L YF T L Y FT L YF T L YF T L




Chapter 8 Pharmacology and Men‘s HealthYFT L YFT L L
YFT L
YFT L
YFT




SECTION 3 Drugs Affecting the Hematopoietic and Immune Systems YFT L YFT L YFT L YFT L YFT L YFT L L
YFT YFT L




Chapter 9 Drug Therapy for Coagulation Disorders
L
YFT YFTL L
YFT L
YFT YFT L L
YFT




YFT Chapter 10 Drug Therapy for Dyslipidemia
L YFT L L
YF T L
YF T YF T L YFT L




Chapter 11 Drug Therapy for Hematopoietic Disorders
L
YFT L
YFT L
YF
T L
YFT L
YFT YFT L




YFT Chapter 12 Drug Therapy: Immunizations
L YFT L L
YF T L
YF T L
YF T




Chapter 13 Drug Therapy to Decrease Immunity
YFT L YFT L Y FT L YFT L YFT L YF T L




YFT Chapter 14 Drug Therapy for the Treatment of Cancer
L YFT L YFT L YFT L YFT L YFT L YFTL L
YFT L
YFT




SECTION 4 Drugs Affecting Inflammation and Infection YFT L YFT L YFT L YFT L L
YFT L
YFT




Chapter 15 Inflammation, Infection, and the Use of Antimicrobial Agents
L
YFT YFT L YFT L L
YFT YFT L YFT L L
YFT L
YFT L
YFT




YFT Chapter 16 Drug Therapy to Decrease Pain, Fever, and Inflammation
L YFT L L
YF T L
YF T YF T L YF T L YFT L YFT L YFT L YF T L




YFT Chapter 17 Drug Therapy With Corticosteroids
L YFT L L
YF T L
YF T YF T L YF T L




Chapter 18 Drug Therapy With Beta-Lactam Antibacterial Agents
YFT L YFT L Y FT L YFT L YFT L YF T L Y FT L




YFT Chapter 19 Drug Therapy With Aminoglycosides and Fluoroquinolones
L L
YFT L
YFT L
YFT L
YFT L
YFT YFT L L
YFT




Chapter 20 Drug Therapy With Tetracyclines, Sulfonamides, and Urinary Antiseptics
YFT L YFT L Y FT L YFT L YFT L YFT L YFT L YF T L YFT L




YFT Chapter 21 Drug Therapy With Macrolides and Miscellaneous Anti-infective Agents
L YFT L L
YF T L
YF T YF T L YF T L YF T L YFT L YFT L YF T L




YFT Chapter 22 Drug Therapy for Tuberculosis and Mycobacterium avium Complex Disease
L YFT L YFT L YFT L L
YFT YFTL YFT L YFT L YFTL YFT L L
YFT




YFT Chapter 23 Drug Therapy for Viral Infections
L YFT L L
YF T L
YF T YF T L YFT L YFT L




2|P a g e L
YFT L
YFT YFT L Y FT L Y FT L

,Chapter 24 Drug Therapy for Fungal Infections
YFT L YFT L Y FT L YFT L YFT L Y FT L




YFT L Chapter 25 Drug Therapy for Parasitic Infections
L
YFT L
YFT YFT L YFT L YFT L L
YFT




SECTION 5 Drugs Affecting the Cardiovascular System L
YFT L
YFT L
YFT YFT L YFT L YFT L




Chapter 26 Drug Therapy for Hypertension
YFT L YFT L YFT L YFT L YFT L




YFT L Chapter 27 Drug Therapy for Dysrhythmias L
YFT L
YFT L
YF
T L
YFT L
YFT




Chapter 28 Drug Therapy for Coronary Heart Disease
L
YFT YFT L YF
TL L
YFT YFT L L
YFT YFT L




YFT L Chapter L
YFT 29 L
YFT Drug YFT L Therapy L
YFT for YFT L Shock YFTL and

YFT Hypotension Chapter 30 Drug Therapy for Heart
L YFT L YFT L YF T L YF T L YFT L L
YF T




YFT L Failure

SECTION 6 Drugs Affecting the Respiratory System L
YFT L
YFT L
YFT YFT L YFT L YFT L




Chapter 31 Drug Therapy for Nasal Congestion and Cough
YFT L YFT L YFT L YFT L YFT L L
YFT L
YFT YFT L




Chapter 32 Drug Therapy to Decrease Histamine Effects and Allergic Response
L
YFT YFT L L
YFT L
YFT L
YFT L
YFT L
YFT L
YFT YFT L L
YFT




YFT L Chapter 33 Drug Therapy for Asthma and Bronchoconstriction
YFT L L
YF T L
YF T L
YF T YFTL YF T L YF T L




SECTION 7 Drugs Affecting the Renal and Digestive Systems L
YFT L
YFT YFT L YFT L YFT L L
YFT YFT L YFT L




Chapter 34 Drug Therapy for Fluid Volume Excess
YFT L YFT L YFT L YFT L YFT L L
YFT YFT L




Chapter 35 Nutritional Support Products, Vitamins, and Mineral Supplements
L
YFT YFT L L
YFT YFT L YFT L L
YFT L
YFT L
YFT




YFT L Chapter 36 Drug Therapy for Weight Management
YFT L L
YF T L
YF T L
YF T YFTL YFT L




Chapter 37 Drug Therapy for Peptic Ulcer Disease and Hyperacidity
L
YFT YFT L L
YFT L
YFT YFT L L
YFT YFT L L
YFT L
YFT




YFT L Chapter 38 Drug Therapy for Nausea and Vomiting
YFT L L
YF T L
YF T L
YF T YFTL YFT L YF T L




Chapter 39 Drug Therapy for Constipation and Elimination Problems
L
YFT YFT L L
YFT L
YFT YFT L L
YFT L
YFT L
YFT




YFT L Chapter 40 Drug Therapy for Diarrhea YFT L L
YF T L
YF T L
YF T YFTL




SECTION 8 Drugs Affecting the Endocrine System L
YFT L
YFT L
YFT L
YFT L
YFT YFT L




YFT L Chapter 41 Drug Therapy for Diabetes Mellitus
YFT L L
YF T L
YF T L
YF T YFTL YF T L




Chapter 42 Drug Therapy for Hyperthyroidism and Hypothyroidism
YFT L YFT L Y FT L YFT L YFT L YF T L YF TL




YFT L Chapter 43 Drug Therapy for Pituitary and Hypothalamic Dysfunction
YFT L L
YF T L
YF T L
YF T YFTL YFT L YF T L YF T L




YFT L Chapter 44 Drug Therapy to Regulate Calcium and Bone Metabolism
YFT L L
YF T L
YF T L
YF T YF T L YFT L Y FT L YF T L L
YF T




YFT L Chapter 45 Drug Therapy for Addison‘s Disease and Cushing‘s
YFT L L
YF T L
YF T L
YF T YFTL YF T L YF T L YFT L




YFT L Disease Section 9 Drugs Affecting the Autonomic and Central
YF T L YFT L YFT L YFTL L
YFT L
YFT L
YFT YFT L




YFT Nervous System
L YFT L




3|P a g e L
YFT L
YFT YFT L Y FT L Y FT L

, Chapter 46 Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of
YFT L YFT L L
YFT YFT L YFT L YFT L L
YFT L
YFT L
YFT L
YFT L
YFT L
YFT L
YFT L
YFT L
YFT




Drug Therapy
YFT L L
YF T




Chapter 47 Drug Therapy for Myasthenia Gravis, Alzheimer‘s Disease, and Urinary Retention
L
YFT YFT L YFT L L
YFT YFTL L
YFT YFT L L
YFT L
YFT L
YFT L
YFT




Chapter 48 Drug Therapy for Parkinson‘s Disease, Urinary Spasticity, and Disorders
YFT L YFT L L
YFT L
YFT L
YFT L
YFT YFTL L
YFT L
YFT L
YFT




Requiring Anticholinergic Drug Therapy
YFT L Y FT L Y FT L Y FT L




Chapter 49 Drug Therapy With Opioids YFT L YFT L YFT L L
YFT YFT L




Chapter 50 Drug Therapy With Local Anesthetics YFT L YF T L L
YF T YF TL YF TL YFT L




YFT L Chapter YFT L 51 YFTL Drug L
YFT Therapy L
YFT With YFT L General

YFT L Anesthetics

Chapter 52 Drug Therapy for Migraines and Other YFT L YFT L YFT L L
YFT YFT L YF TL YFT L




YFT L Headaches Chapter 53 Drug Therapy for Seizure Disorders YF T L L
YFT L
YFT L
YFT YFT L L
YFT L
YFT




L
YFT and Spasticity Chapter 54 Drug Therapy for Anxiety and
YFT L YFT L YFT L YFT L Y FT L YFT L YFT L L
YF T




YFT L Insomnia

Chapter 55 Drug Therapy for Depression and Mood Stabilization L
YFT YFT L YFT L YFT L YFTL L
YFT YFT L YFT L




YFT L Chapter 56 Drug Therapy for Psychotic Disorders YFT L YF T L L
YF T YF T L L
YFT YF T L




Chapter 57 Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy
YFT L YFT L YFTL YFT L YFTL L
YFT YFT L L
YFT L
YFT L
YFT




YFT L Chapter 58 Drug Therapy for Substance Abuse Disorders YFT L YF T L L
YF T YF T L L
YFT Y FT L YF T L




Section 10 Drugs Affecting the Eye, Ear, and Skin YFT L YFT L YFT L YFT L YFT L L
YFT L
YFT L
YFT




YFT L Chapter 59 Drug Therapy for Disorders of the Eye YF T L YF T L YF T L YF T L YFT L L
YF T YFT L YF T L




YFT L Chapter 60 Drug Therapy for Disorders of the Ear YFT L YF T L L
YF T YF T L L
YFT YF T L Y FT L YF T L




YFT L Chapter 61 Drug Therapy for Disorders of the Skin YFT L YF T L L
YF T YF T L L
YFT YF T L Y FT L YF T L




Chapter 1 : The Foundation of Pharmacology: Quality and Safety : YFT L YFT L YFT L YFT L L
YFT YFT L L
YFT L
YFT L
YFT L
YFT




1. A woman diagnosed with obsessive–compulsive disorder has been prescribed oral
L
YFT YFT L YFT L YFT L L
YFT L
YFT L
YFT L
YFT L
YFT




paroxetine hydrochloride. What is the expected effect for this prescription?
L
YFT YF TL YF T L YFT L YF T L Y FT L YF TL L
YFT L
YF T YFT L




A. Curative effect on symptoms YFTL YFT L YFT L




B. Systemic effect on symptoms YFTL YFT L YFTL




C. Local effect on symptoms L
YFT YF T L YFTL




D. Parenteral effect on symptoms L
T
F
Y YF
T L L
T
F
Y




YFT L ANS: B L
YF T




4|P a g e L
YFT L
YFT YFT L Y FT L Y FT L